Torrent Pharmaceuticals Limited has informed the Exchange about press release dated 17-Mar-2022 titled Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment